What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials?
| Autor: | Bosi, Guilherme Rasia, Fogliatto, Laura Maria, Costa, Tito Emilio Vanelli, Grokoski, Kamila Castro, Pereira, Mariana Pinto, Bugs, Nathan, Kalil, Marco, Fraga, Christina, Daudt, Liane Esteves, Silla, Lucia Mariano da Rocha |
|---|---|
| Zdroj: | In Hematology, Transfusion and Cell Therapy July-September 2019 41(3):222-228 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|